Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Neoplasia (New York, N.Y.)|December 17, 2013
ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cellsHans-Peter Kantner, Wolfgang Warsch, Alessio Delogu, et al.Cancer Letters|January 26, 2025
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemiaStefanie Weiss, Bernhard Zdársky, Agnieszka Witalisz-Siepracka, et al.Blood|December 4, 2010
A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and developmentEva Eckelhart, Wolfgang Warsch, Eva Zebedin, et al.Cancer Cell|July 18, 2006
STAT1 acts as a tumor promoter for leukemia developmentBoris Kovacic, Dagmar Stoiber, Richard Moriggl, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphomaJudith Lind, Roland Hellinger, Petra Kudweis, et al.Nature|July 23, 2003
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defenceAkinori Takaoka, Sumio Hayakawa, Hideyuki Yanai, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenesSilvia Stockinger, Tilo Materna, Dagmar Stoiber, et al.Blood|February 11, 2003
Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formationVeronika Sexl, Boris Kovacic, Roland Piekorz, et al.Plos Pathogens|June 22, 2012
Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infectionElisabeth Kernbauer, Verena Maier, Dagmar Stoiber, et al.Frontiers in Pharmacology|July 29, 2024
How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levelsAlexander Tinchon, Joana Brait, Sascha Klee, et al.Pageof 7